alpha-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients (original) (raw)

α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients

Marina Gruden, Ludmilla Morozova-roche

PLoS ONE, 2011

View PDFchevron_right

Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease

Leslie Shaw

Journal of neurochemistry, 2018

View PDFchevron_right

Detection of Oligomeric Forms of {Alpha}-Synuclein Protein In Human Plasma As a Potential Biomarker for Parkinson's Disease

Sultan Salem

The FASEB Journal, 2006

View PDFchevron_right

Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease

Omar El-agnaf

The FASEB journal, 2006

View PDFchevron_right

Plasma α-synuclein is decreased in subjects with Parkinson's disease

Su Mok

Experimental Neurology, 2007

View PDFchevron_right

Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels

Ludmilla Morozova-Roche

ACS chemical neuroscience, 2017

View PDFchevron_right

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference

Takahiko Tokuda, Omar El-agnaf

PloS one, 2015

View PDFchevron_right

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough

soumya pal

Frontiers in Aging Neuroscience

View PDFchevron_right

An impedimetric assay of α-synuclein autoantibodies in early stage Parkinson's disease

Kevin Talbot

View PDFchevron_right

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

Vladimir Kostic

Movement Disorders, 2005

View PDFchevron_right

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease OPEN

Hugo Vicente Miranda

View PDFchevron_right

Detection of oligomeric forms of -synuclein protein in human plasma as a potential biomarker for Parkinson's disease

David Allsop, Omar El-agnaf

The FASEB Journal, 2006

View PDFchevron_right

α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls

Suaad Elhadi

Annals of Clinical and Translational Neurology, 2019

View PDFchevron_right

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

John Hardy

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003

View PDFchevron_right

Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson's Disease Relative to Alzheimer's Disease and Controls

Ali Shalash

Frontiers in neurology, 2017

View PDFchevron_right

Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

Alessandro Negro

Neuroscience Letters, 2000

View PDFchevron_right

Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review

Donald Grosset

Acta Neurologica Scandinavica, 2014

View PDFchevron_right

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease

Elisa Miranda

Scientific reports, 2017

View PDFchevron_right

-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

David Allsop, Omar El-agnaf

The FASEB Journal, 2003

View PDFchevron_right

Alpha-Synuclein: Biomarker for Parkinson’s Disease, It’s Estimation Methods, and Targeted Medicinal Therapies

vaishali undale

2021

View PDFchevron_right

In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody

Erwin Schleicher

Acta Neuropathologica, 2014

View PDFchevron_right

Autoantibodies to alpha-synuclein in inherited Parkinson’s disease

Georgia Xiromerisiou

Journal of Neurochemistry, 2006

View PDFchevron_right

Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

Piu Chan

Experimental Neurology, 1998

View PDFchevron_right

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease

Tingting Du

Frontiers in Aging Neuroscience, 2021

View PDFchevron_right

CSF α-synuclein does not differentiate between parkinsonian disorders

Maqbul Ahmad

Neurobiology of Aging, 2012

View PDFchevron_right

Increased immune activation by pathologic alpha‐synuclein in Parkinson's Disease

Karin Danzer

Annals of Neurology

View PDFchevron_right